Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients
Clinical trial NCT06212076 · RECRUITING
Trial details
- NCT number
- NCT06212076
- Sponsor
- Nanjing Immunophage Biotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-11
- Primary completion
- 2027-07-09
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.